Residual Tumor and Response to Treatment

Members

Fabien Reyal, MD, PhD

Reyal

Fabien Reyal Team Leader Team Reyal Back to the list

Key publications

Year of publication 2015

Bonsang-Kitzis H1, Sadacca B2, Hamy-Petit AS3, Moarii M4, Pinheiro A3, Laurent C3, Reyal F1. (2019 Jun 24)

Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.

Oncoimmunology : 5 : 1061176 : DOI : 10.1080/2162402X.2015.1061176
Cristina Ghirelli, Fabien Reyal, Marine Jeanmougin, Raphaël Zollinger, Philémon Sirven, Paula Michea, Christophe Caux, Nathalie Bendriss-Vermare, Marie-Hélène Donnadieu, Martial Caly, Virginie Fourchotte, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, Xavier Sastre-Garau, Vassili Soumelis (2015 May 16)

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes.

Cancer research : 2775-87 : DOI : 10.1158/0008-5472.CAN-14-2386

Year of publication 2012

Angélique Bobrie, Sophie Krumeich, Fabien Reyal, Chiara Recchi, Luis F Moita, Miguel C Seabra, Matias Ostrowski, Clotilde Théry (2012 Aug 3)

Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.

Cancer research : 4920-30 : DOI : 10.1158/0008-5472.CAN-12-0925